Fundraising Fox

Onchilles Pharma

San Diego, US · Founded 2017 · Delaware corporation · 1 known investors

Onchilles Pharma is a biopharmaceutical company developing novel therapeutics based on scientific research to address unmet medical needs. The company is led by a team with academic and industry backgrounds in drug development.

Biotech

Founders & leadership

Onchilles Pharma was founded in 2017 by Lev Becker, Ph.D..

LB
Lev Becker, Ph.D.Founder
CT
Court TurnerNamed on SEC filing
KL
Kevin Li, Ph.D.Named on SEC filing
MNMarc Nasoff
Marc NasoffChief Development Officer

Investors · 1

InVivium CapitalChicago

Funding

SEC filings, press & company announcements

$3.6M disclosed across 1 of 3 rounds · 2020–2025

▶$3.6MraisedJul 2020 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Court TurnerExecutive Officer, Director
  • Kevin Li, Ph.D.Director
  • Lev Becker, Ph.D.Director
Offering amount
$7.7M
Amount sold
$3.6M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Bioworld70 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Onchilles Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Exclusive: Onchilles raises $25M to take cancer-killing enzyme into human trialsendpoints.news · Nov 2025​​Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisorbusinesswire.com · Nov 2025Onchilles Pharma Publishes Landmark ELANE Pathway Studyonchillespharma.com · Nov 2025Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapyhitconsultant.net · Nov 2025SDBJ: Onchilles Pharma Raises $7M for Targeted Cancer Therapyonchillespharma.com · Jun 2021

Frequently asked questions

What does Onchilles Pharma do?
Onchilles Pharma is a biopharmaceutical company developing novel therapeutics based on scientific research to address unmet medical needs. The company is led by a team with academic and industry backgrounds in drug development.
Who founded Onchilles Pharma?
Onchilles Pharma was founded by Lev Becker, Ph.D. in 2017.
Who are Onchilles Pharma's investors?
Onchilles Pharma's investors include InVivium Capital.
How much funding has Onchilles Pharma raised?
Onchilles Pharma has disclosed $3.6M raised across 1 of its 3 known rounds.
Where is Onchilles Pharma headquartered?
Onchilles Pharma is headquartered in San Diego, US.